Eight researchers specializing in adult oncology with Fred Hutch Cancer Center and the University of…
karnottJuly 3, 2025
A vaccine that provides robust, durable protection against malaria remains a global health priority. Although…
karnottJuly 2, 2025
Bothell-based biotech company Achieve Life Sciences Inc. announced plans to raise $45M through an underwritten…
karnottJuly 2, 2025
Some of our most challenging health conditions result from genetic disorders like sickle cell disease…
karnottJuly 1, 2025
The field of pancreatic cancer needs a measurable biological difference — a biomarker — to…
karnottJuly 1, 2025
Rising Leaders is a course designed to bring practical leadership skills to School of Medicine…
karnottJune 30, 2025
As immune function wanes, people become vulnerable. What should be a sniffle becomes deadly pneumonia.…
karnottJune 30, 2025
Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules
Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based…
karnottJune 27, 2025
